NCT02961998View on ClinicalTrials.gov

Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

PHASE4CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

Celecoxib

Patients from experimental group will take celecoxib, except for sorafenib

DRUG

Sorafenib

Each group will receive sorafenib as basic treatment.

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT02961998 - Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail | Biotech Hunter | Biotech Hunter